These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17667884)

  • 1. Clopidogrel desensitization protocol for the treatment of thienopyridine hypersensitivity.
    Walker NE; Fasano MB; Hobbs RA; Horwitz PA
    Crit Pathw Cardiol; 2007 Mar; 6(1):26-9. PubMed ID: 17667884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization for the management of clopidogrel hypersensitivity: initial clinical experience.
    Walker NE; Fasano MB; Horwitz PA
    J Invasive Cardiol; 2006 Jul; 18(7):341-4. PubMed ID: 16816444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel desensitization: case report and review of published protocols.
    Owen P; Garner J; Hergott L; Page RL
    Pharmacotherapy; 2008 Feb; 28(2):259-70. PubMed ID: 18225971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clopidogrel hypersensitivity: a novel multi-day outpatient oral desensitization regimen.
    Fajt M; Petrov A
    Ann Pharmacother; 2010 Jan; 44(1):11-8. PubMed ID: 20009004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent.
    Satish B; Tressa K; Harish CR
    Crit Pathw Cardiol; 2007 Mar; 6(1):24-5. PubMed ID: 17667883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful clopidogrel desensitization after drug-eluting stent implantation.
    Kammer RT
    J Invasive Cardiol; 2009 Mar; 21(3):134-5. PubMed ID: 19258645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents.
    Makkar K; Wilensky RL; Julien MB; Herrmann HC; Spinler SA
    Ann Pharmacother; 2006 Jun; 40(6):1204-7. PubMed ID: 16684808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting.
    Silberman S; Neukirch-Stoop C; Steg PG
    Am J Cardiol; 2005 Feb; 95(4):509-10. PubMed ID: 15695141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel desensitization after drug-eluting stent placement.
    von Tiehl KF; Price MJ; Valencia R; Ludington KJ; Teirstein PS; Simon RA
    J Am Coll Cardiol; 2007 Nov; 50(21):2039-43. PubMed ID: 18021870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid desensitization protocols for patients with cardiovascular disease and aspirin hypersensitivity in an era of dual antiplatelet therapy.
    Page NA; Schroeder WS
    Ann Pharmacother; 2007 Jan; 41(1):61-7. PubMed ID: 17200429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
    Rossini R; Angiolillo DJ; Musumeci G; Scuri P; Invernizzi P; Bass TA; Mihalcsik L; Gavazzi A
    Am J Cardiol; 2008 Mar; 101(6):786-9. PubMed ID: 18328841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and tolerability of a clopidogrel desensitization protocol].
    Estefanell-Tejero A; López-Cabezas C; Riu-Viladoms G; Falces-Salvador C
    Med Clin (Barc); 2012 May; 138(15):684-5. PubMed ID: 22015006
    [No Abstract]   [Full Text] [Related]  

  • 13. Desensitization to clopidogrel: a growing need.
    Sanchez-Lopez J; Muñoz-Cano R; Bartra J; Valero A; Picado C
    Allergy; 2010 Feb; 65(2):279-80. PubMed ID: 19796212
    [No Abstract]   [Full Text] [Related]  

  • 14. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel (Plavix) desensitization: a case series.
    Camara MG; Almeda FQ
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):525-7. PubMed ID: 15973671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated profound thrombocytopenia associated with clopidogrel.
    Elmi F; Peacock T; Schiavone J
    J Invasive Cardiol; 2000 Oct; 12(10):532-5. PubMed ID: 11022215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of allergic or hematologic adverse reactions to ticlopidine among patients with allergic or hematologic adverse reactions to clopidogrel.
    Lokhandwala JO; Best PJ; Butterfield JH; Skelding KA; Scott T; Blankenship JC; Buckley JW; Berger PB
    Circ Cardiovasc Interv; 2009 Aug; 2(4):348-51. PubMed ID: 20031738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel: who, when, and how?
    Cannon CP
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S27-34. PubMed ID: 17917618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification.
    Neubauer H; Lask S; Engelhardt A; Mügge A
    Thromb Haemost; 2008 Feb; 99(2):357-62. PubMed ID: 18278186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.